‌

US Patent 8765750 Piperazine compound having a PGDS inhibitory effect

Patent 8765750 was granted and assigned to Taiho Pharmaceutical on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Taiho Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87657500

Patent Inventor Names

Makoto Kitade0

Yoshihiro Urade0

Katsunao Tanaka0

Kazuhiko Shigeno0

Keiko Yamane0

Date of Patent

July 1, 2014

Patent Application Number

135226050

Date Filed

January 19, 2011

Patent Citations Received

‌

US Patent 11883410 Preventative and therapeutic agents for sarcopenia

Patent Primary Examiner

Emily Bernhardt

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8765750 Piperazine compound having a PGDS inhibitory effect

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API